Baculovirus as a gene delivery vector: Recent understandings of molecular alterations in transduced cells and latest applications

Biotechnology Advances

Volumn 29, Issue 6, 2011, Pages 618-631

  Chen, Chi Yuan ^a   Lin, Chin Yu ^a   Chen, Guan Yu ^a   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Antiviral therapy; Baculovirus; Cancer therapy; Immune responses; Tissue engineering; Vaccine

Indexed keywords

ANTIVIRAL THERAPY; BACULOVIRUS; CANCER THERAPY; CELLULAR RESPONSE; GENE DELIVERY VECTORS; IMMUNE RESPONSE; MOLECULAR MECHANISM; REGENERATIVE MEDICINE;

CLONE CELLS; CLONING; DISEASES; GENE THERAPY; GENE TRANSFER; MAMMALS; ONCOLOGY; TISSUE; TISSUE ENGINEERING; VACCINES;

MOLECULAR BIOLOGY;

BIOSAFETY; CANCER; GENETIC ENGINEERING; IMMUNE RESPONSE; INSECT; MOLECULAR ANALYSIS; PATHOGEN; TOXICITY; VACCINE; VIRUS;

ANIMAL; BACULOVIRUS; BIOTECHNOLOGY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METHODOLOGY; REVIEW; TISSUE ENGINEERING;

ANIMALS; BACULOVIRIDAE; BIOTECHNOLOGY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; TISSUE ENGINEERING; TRANSDUCTION, GENETIC;

AVES; HEXAPODA; MAMMALIA;

EID: 80053453533     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2011.04.004     Document Type: Review

References (230)

1. Abe T., Matsuura Y. Host innate immune responses induced by baculovirus in mammals. Curr Gene Ther 2010, 10:226-231.
2. Abe T., Takahashi H., Hamazaki H., et al. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 2003, 171:1133-1139.
3. Abe T., Hemmi H., Miyamoto H., et al. Involvement of the toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 2005, 79:2847-2858.
4. Abe T., Kaname Y., Wen X., et al. Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J Virol 2009, 83:7629-7640.
5. Airenne K.J., Hiltunen M.O., Turunen M.P., et al. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther 2000, 7:1499-1504.
6. Aoki H., Sakoda Y., Jukuroki K., et al. Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet Microbiol 1999, 68:197-207.
7. Bai B., Lu X., Meng J., et al. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. Mol Immunol 2008, 45:868-875.
8. Bak X.-Y., Yang J., Wang S. Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy. Cancer Gene Ther 2010, 17:721-729.
9. Bak X.Y., Dang H.L., Yang J., et al. Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma. Hum Gene Ther 2011, Epub ahead of print. 10.1089/hum.2010.212.
10. Balani P., Boulaire J., Zhao Y., et al. High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment. Mol Ther 2009, 17:1003-1011.
11. Bernal V., Carinhas N., Yokomizo A.Y., et al. Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism. Biotechnol Bioeng 2009, 104:162-180.
12. Blagborough A.M., Yoshida S., Sattabongkot J., et al. Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission. Vaccine 2010, 28:6014-6020.
13. Borg J., Nevsten P., Wallenberg R., et al. Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase. J Biotechnol 2004, 114:21-30.
14. Boulaire J., Zhao Y., Wang S. Gene expression profiling to define host response to baculoviral transduction in the brain. J Neurochem 2009, 109:1203-1214.
15. Cao Y., Lu Z., Sun P., et al. A pseudotype baculovirus expressing the capsid protein of foot-and-mouth disease virus and a T-Cell immunogen shows enhanced immunogenicity in mice. Virol J 2011, E-pub ahead of print. 10.1186/743-422X-8-77.
16. Carinhas N., Bernal V., Yokomizo A.Y., et al. Baculovirus production for gene therapy: the role of cell density, multiplicity of infection and medium exchange. Appl Microbiol Biotechnol 2009, 81:1041-1049.
17. Carinhas N., Bernal V., Monteiro F., et al. Improving baculovirus production at high cell density through manipulation of energy metabolism. Metab Eng 2010, 12:39-52.
18. Chan Z.-R., Lai C.-W., Lee H.-P., et al. Determination of the baculovirus transducing titer in mammalian cells. Biotechnol Bioeng 2006, 93:564-571.
19. Chang Y.-J., Liu C.-Y., Chiang B.-L., et al. Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: Identification of two functional regions. J Immunol 2004, 173:7602-7614.
20. Chapple S.D.J., Jones I.M. Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchor. J Biotechnol 2002, 95:269-275.
21. Chen Y.-H., Wu J.-C., Wang K.-C., et al. Baculovirus-mediated production of HDV-like particles in BHK cells using a novel oscillating bioreactor. J Biotechnol 2005, 118:135-147.
22. Chen H.-C., Lee H.-P., Ho Y.-C., et al. Combination of baculovirus-mediated gene transfer and rotating-shaft bioreactor for cartilage tissue engineering. Biomaterials 2006, 27:3154-3162.
23. Chen H.-C., Sung L.-Y., Lo W.-H., et al. Combination of baculovirus-mediated BMP-2 expression and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther 2008, 15:309-317.
24. Chen G.-Y., Chen C.-Y., Chang M.D.-T., et al. Concanavalin A affinity chromatography for efficient baculovirus purification. Biotechnol Prog 2009, 25:1669-1677.
25. Chen G.-Y., Shiah H.-C., Su H.-J., et al. Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 (TLR3) pathway. J Virol 2009, 83:10548-10556.
26. Chen H.-C., Chang Y.-H., Chuang C.-K., et al. The repair of osteochondral defects using baculovirus-mediated gene transfer with de-differentiated chondrocytes in bioreactor culture. Biomaterials 2009, 30:674-681.
27. Chen C.-Y., Liu H.-J., Tsai C.-P., et al. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms. Vaccine 2010, 28:7644-7651.
28. Chen C.-Y., Wu H.-H., Chen C.-P., et al. Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Mol Pharm 2011, Epub ahead of print. 10.1021/mp100368d.
29. Chen H.-Z., Liu C.Y.-Y., Wu C.-P., et al. Membrane penetrating peptides greatly enhance baculovirus transduction efficiency into mammalian cells. Biochem Biophys Res Commun 2011, 405:297-302.
30. Cheng T., Xu C.-Y., Wang Y.-B., et al. A rapid and efficient method to express target genes in mammalian cell by baculovirus. World J Gastroenterol 2004, 10:1612-1618.
31. Cheshenko N., Krougliak N., Eisensmith R.C., et al. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 2001, 8:846-854.
32. Chuang C.-K., Sung L.-Y., Hwang S.-M., et al. Baculovirus as a new gene delivery vector for stem cells engineering and bone tissue engineering. Gene Ther 2007, 14:1417-1424.
33. Chuang C.-K., Wong T.-H., Hwang S.-M., et al. Baculovirus transduction of mesenchymal stem cells: In vitro responses and in vivo immune responses after cell transplantation. Mol Ther 2009, 17:889-896.
34. Chuang C.-K., Lin K.-J., Lin C.-Y., et al. Xenotransplantation of human mesenchymal stem cells into immunocompetent rats for calvarial bone repair. Tissue Eng Part A 2010, 16:479-488.
35. Condreay J.P., Kost T.A. Baculovirus expression vectors for insect and mammalian cells. Curr Drug Targets 2007, 8:1126-1131.
36. Condreay J.P., Witherspoon S.M., Clay W.C., et al. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci U S A 1999, 96:127-132.
37. Condreay J.P., Ames R.S., Hassan N.J., et al. Baculoviruses and mammalian cell-based assays for drug screening. Adv Virus Res 2006, 68:255-286.
38. Dojima T., Nishina T., Kato T., et al. Production of scFv-displaying BmNPV in silkworm larvae and its efficient purification. Biotechnol Appl Biochem 2010, 57:63-69.
39. Dong S.C., Wang M.L., Qiu Z.J., et al. Autographa californica multicapsid nucleopolyhedrovirus efficiently infects Sf9 cells and transduces mammalian cells via direct fusion with the plasma membrane at low pH. J Virol 2010, 84:5351-5359.
40. Du J., Zeng J.M., Zhao Y., et al. The combined use of viral transcriptional and post-transcriptional regulatory elements to improve baculovirus-mediated transient gene expression in human embryonic stem cells. J Biosci Bioeng 2010, 109:1-8.
41. Duisit G., Saleun S., Douthe S., et al. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. J Gene Med 1999, 1:93-102.
42. Efrose R., Swevers L., Iatrou K. Baculoviruses deficient in ie1 gene function abrogate viral gene expression in transduced mammalian cells. Virology 2010, 406:293-301.
43. Ernst W., Schinko T., Spenger A., et al. Improving baculovirus transduction of mammalian cells by surface display of a RGD-motif. J Biotechnol 2006, 126:237-240.
44. Facciabene A., Aurisicchio L., La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 2004, 78:8663-8672.
45. Fan H.-Y., Pan Y.-F., Fang L.-R., et al. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J Virol Methods 2008, 150:21-26.
46. Fang R., Feng H., Nie H., et al. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Vaccine 2010, 28:1803-1807.
47. Feng Q., Liu Y.-Y., Qu X.-X., et al. Baculovirus surface display of SARS coronavirus (SARS-CoV) spike protein and immunogenicity of the displayed protein in mice models. DNA Cell Biol 2006, 25:668-673.
48. ® for rapid baculovirus quantitation. J Virol Methods 2011, 171:111-116.
49. Fujita R., Matsuyama T., Yamagishi J., et al. Expression of Autographa californica multiple nucleopolyhedrovirus genes in mammalian cells and upregulation of the host β-actin gene. J Virol 2006, 80:2390-2395.
50. Gao R., McCormick C.J., Arthur M.J.P., et al. High efficiency gene transfer into cultured primary rat and human hepatic stellate cells using baculovirus vectors. Liver 2002, 22:15-22.
51. Gao H., Wang Y., Li N., et al. Efficient gene delivery into mammalian cells mediated by a recombinant baculovirus containing a whispovirus ie1 promoter, a novel shuttle promoter between insect cells and mammalian cells. J Biotechnol 2007, 131:138-143.
52. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010, 9:775-789.
53. Ge J., Huang Y.-S., Hu X.-T., et al. A surface-modified baculovirus vector with improved gene delivery to B-lymphocytic cells. J Biotechnol 2007, 129:367-372.
54. Georgopoulos L.J., Elgue G., Sanchez J., et al. Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood. Mol Immunol 2009, 46:2911-2917.
55. Gerner C., Haudek-Prinz V.J., Lackner A., et al. Indications for cell stress in response to adenoviral and baculoviral gene transfer observed by proteome profiling of human cancer cells. Electrophoresis 2010, 31:1822-1832.
56. Gilbert L., Valilehto O., Kirjavainen S., et al. Expression and subcellular targeting of canine parvovirus capsid proteins in baculovirus-transduced NLFK cells. FEBS Lett 2005, 579:385-392.
57. Grabherr R., Ernst W. Baculovirus for eukaryotic protein display. Curr Gene Ther 2010, 10:195-200.
58. Grabherr R., Ernst W., Oker-Blom C., Jones I. Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins. Trends Biotechnol. 2001, 19:231-236.
59. Grabowska A.K., Lipinska A.D., Rohde J., et al. New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection. Vaccine 2009, 27:3584-3591.
60. Grassi G., Kohn H., Dapas B., et al. Comparison between recombinant baculo- and adenoviral-vectors as transfer system in cardiovascular cells. Arch Virol 2006, 151:255-271.
61. Guo R., Zhang Y.-F., Liang S., et al. Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells. Nucl Med Commun 2010, 31:916-921.
62. Guo H., Choudhury Y., Yang J., et al. Antiglioma effects of combined use of a baculovirual vector expressing wild-type p53 and sodium butyrate. J Gene Med 2011, 13:26-36.
63. Han Y., Niu M.-S., An L.-J., et al. Upregulation of proinflammatory cytokines and NO production in BV-activated avian macrophage-like cell line (HD11) requires MAPK and NF-κB pathways. Int Immunopharmacol 2009, 9:817-823.
64. Han Y., Niu M.-S., An L.-J., et al. Involvement of TLR21 in baculovirus-induced interleukin-12 gene expression in avian macrophage-like cell line HD11. Vet Microbiol 2010, 144:75-81.
65. He F., Ho Y.-F., Yu L., et al. WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine. BMC Microbiol 2008, 8.
66. Hervas-Stubbs S., Rueda P., Lopez L., et al. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 2007, 178:2361-2369.
67. Hitchman R.B., Possee R.D., King L.A. Baculovirus expression systems for recombinant protein production in insect cells. Recent Pat Biotechnol 2009, 3:46-54.
68. Ho Y.-C., Chen H.-C., Wang K.-C., et al. Highly efficient baculovirus-mediated gene transfer into rat chondrocytes. Biotechnol Bioeng 2004, 88:643-651.
69. Ho Y.-C., Chung Y.-C., Hwang S.-M., Wang K.-C., Hu Y.-C. Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. J Gene Med 2005, 7:860-868.
70. Ho Y.-C., Lee H.-P., Hwang S.-M., et al. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states. Gene Ther 2006, 13:1471-1479.
71. Hoare J., Waddington S., Thomas H.C., et al. Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in mice. J Gene Med 2005, 7:325-333.
72. Hofmann C., Huser A., Lehnert W., et al. Protection of baculovirus-vectors against complement-mediated inactivation by recombinant soluble complement receptor type 1. Biol Chem 1999, 380:393-395.
73. Hu Y.-C. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 2005, 26:405-416.
74. Hu Y.-C. Baculovirus vectors for gene therapy. Adv Virus Res 2006, 68:287-320.
75. Hu Y.-C. Baculoviral vectors for gene delivery: a review. Curr Gene Ther 2008, 8:54-65.
76. Hu Y.-C., Tsai C.-T., Chang Y.-J., et al. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog 2003, 19:373-379.
77. Hu Y.-C., Yao K., Wu T.-Y. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 2008, 7:363-371.
78. Huang K.-S., Lo W.-H., Chung Y.-C., et al. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. Hum Gene Ther 2007, 18:1161-1170.
79. Huang W., Tian X.-L., Wu Y.-L., et al. Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene. World J Gastroenterol 2008, 14:5810-5815.
80. Huang F., Cao S., Cui X., et al. Efficient gene delivery into fish cells by an improved recombinant baculovirus. J Virol Methods 2011, 173:294-299.
81. Huser A., Rudolph M., Hofmann C. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nat Biotechnol 2001, 19:451-455.
82. Ihalainen T.O., Laakkonen J.P., Paloheimo O., et al. Morphological characterization of baculovirus Autographa californica multiple nucleopolyhedrovirus. Virus Res 2010, 148:71-74.
83. Ishii K.J., Koyama S., Nakagawa A., et al. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008, 3:352-363.
84. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
85. Jardin B.A., Zhao Y., Selvaraj M., et al. Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system. J Biotechnol 2008, 135:272-280.
86. Jin R., Lv Z., Chen Q., et al. Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx mori. PLoS One 2008, 3:e3933.
87. Jorio H., Tran R., Meghrous J., et al. Analysis of baculovirus aggregates using flow cytometry. J Virol Methods 2006, 134:8-14.
88. Kaikkonen M.U., Raty J.K., Airenne K.J., et al. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther 2006, 13:304-312.
89. Kaikkonen M.U., Viholainen J.I., Narvanen A., et al. Targeting and purification of metabolically biotinylated baculovirus. Hum Gene Ther 2008, 19:589-600.
90. Kaikkonen M.U., Maatta A.I., Yla-Herttuala S., et al. Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery. Mol Ther 2010, 18:987-992.
91. Kaname Y., Tani H., Kataoka C., et al. Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. J Virol 2010, 84:3210-3219.
92. Kaneko H., Suzuki H., Abe T., Miyano-Kurosaki N., Takaku H. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells. Biochem Biophys Res Commun 2006, 349:1220-1227.
93. Kärkkäinen H.R., Lesch H.P., Määttä A.I., et al. A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells. BMC Res Notes 2009, 23:63.
94. Keil G.M., Klopfleisch C., Giesow K., et al. Novel vectors for simultaneous high-level dual protein expression in vertebrate and insect cells by recombinant baculoviruses. J Virol Methods 2009, 160:132-137.
95. Kenoutis C., Efrose R.C., Swevers L., et al. Baculovirus-mediated gene delivery into mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression. J Virol 2006, 80:4135-4146.
96. Kim Y.-K., Park I.-K., Jiang H.-L., et al. Regulation of transduction efficiency by pegylation of baculovirus vector in vitro and in vivo. J Biotechnol 2006, 125:104-109.
97. Kim C.-H., Yoon J.-S., Sohn H.-J., et al. Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model. Cancer Lett 2007, 250:276-283.
98. Kim Y.-K., Kwon J.-T., Choi J.-Y., et al. Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus. Cancer Gene Ther 2010, 17:751-760.
99. Kinnunen K., Kalesnykas G., Mahonen A.J., Laidinen S., Holma L., Heikura T., et al. Baculovirus is an efficient vector for the transduction of the eye: Comparison of baculovirus- and adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye. J Gene Med 2009, 11:382-389.
100. Kitagawa Y., Tani H., Kwang C., et al. Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol 2005, 79:3639-3652.
101. Kitajima M., Hamazaki H., Miyano-Kurosaki N., et al. Characterization of baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mammalian cells. Biochem Biophys Res Commun 2006, 343:378-384.
102. Kitajima M., Abe T., Miyano-Kurosaki N., et al. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol Ther 2008, 16:261-268.
103. Kitidee K., Nangola S., Gonzalez G., et al. Baculovirus display of single chain antibody (scFv) using a novel signal peptide. BMC Biotechnol 2010, 10:80.
104. Kost T.A., Condreay J.P. Recombinant baculoviruses as expression vectors for insect and mammalian cells. Curr Opin Biotechnol 1999, 10:428-433.
105. Kost T.A., Condreay J.P. Recombinant baculoviruses as mammalian cell gene delivery vectors. Trends Biotechnol 2002, 20:173-180.
106. Kost T.A., Condreay J.P., Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005, 23:567-575.
107. Kost T.A., Condreay J.P., Ames R.S. Baculovirus gene delivery: a flexible assay development tool. Curr Gene Ther 2010, 10:168-173.
108. Kukkonen S.P., Airenne K.J., Marjomaki V., et al. Baculovirus capsid display: a novel tool for transduction imaging. Mol Ther 2003, 8:853-862.
109. Kumar S., Wan C., Ramaswamy G., et al. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther 2010, 18:1026-1034.
110. Laakkonen J.P., Kaikkonen M.U., Ronkainen P.H.A., et al. Baculovirus-mediated immediate-early gene expression and nuclear reorganization in human cells. Cell Microbiol 2008, 10:667-681.
111. Laakkonen J.P., Makela A.R., Kakkonen E., et al. Clathrin-independent entry of baculovirus triggers uptake of E. coli in non-phagocytic human cells. PLoS One 2009, 4.
112. Lackner A., Genta K., Koppensteiner H., et al. A bicistronic baculovirus vector for transient and stable protein expression in mammalian cells. Anal Biochem 2008, 380:146-148.
113. Lavdas A.A., Efrose R., Douris V., Gaitanou M., Papastefanaki F., Swevers L., et al. Soluble forms of the cell adhesion molecule L1 produced by insect and baculovirus-transduced mammalian cells enhance Schwann cell motility. J Neurochem. 2010, 115:1137-1149.
114. Lee H.-P., Chen Y.-L., Shen H.-C., et al. Baculovirus transduction of rat articular chondrocytes: roles of cell cycle. J Gene Med 2007, 9:33-43.
115. Lee H.-P., Ho Y.-C., Hwang S.-M., et al. Variation of baculovirus-harbored transgene transcription among mesenchymal stem cell-derived progenitors leads to varied expression. Biotechnol Bioeng 2007, 97:649-655.
116. Lee H.-P., Matsuura Y., Chen H.-C., et al. Baculovirus transduction of chondrocytes elicits interferon-α/β and suppresses transgene expression. J Gene Med 2009, 11:302-312.
117. Lee H.-J., Park N., Cho H.-J., et al. Development of a novel viral DNA vaccine against human papillomavirus: AcHERV-HP16L1. Vaccine 2010, 28:1613-1619.
118. Lehtolainen P., Tyynela K., Kannasto J., Airenne K.J., Yla-Herttuala S. Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivo. Gene Ther 2002, 9:1693-1699.
119. Lesch H.P., Turpeinen S., Niskanen E.A., et al. Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther 2008, 15:1280-1286.
120. Lesch H.P., Laitinen A., Peixoto C., et al. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Ther 2011, 18(6):531-538.
121. Levi B., James A.W., Nelson E.R., et al. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One 2010, 5:e11177.
122. Li Y., Wang X., Guo H., et al. Axonal transport of recombinant baculovirus vectors. Mol Ther 2004, 10:1121-1129.
123. Li M., Wang Y.-F., Wang Y., et al. Immune responses induced by a BacMam virus expressing the E2 protein of classical swine fever virus in mice. Immunol Lett 2009, 125:145-150.
124. Li Y.-M., Ye J., Cao S.-B., et al. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. J Gene Med 2009, 11:150-159.
125. Lin Y.-H., Lee L.-H., Shih W.-L., et al. Baculovirus surface display of σC and σB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model. Vaccine 2008, 26:6361-6367.
126. Lin C.-Y., Chang Y.-H., Lin K.-J., et al. The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials 2010, 31:3222-3230.
127. Lin C.-Y., Lu C.-H., Luo W.-Y., et al. Baculovirus as a gene delivery vector for cartilage and bone tissue engineering. Curr Gene Ther 2010, 10:242-254.
128. Lin S.-Y., Chen G.-Y., Hu Y.-C., et al. Recent patents on the baculovirus systems. Recent Pat Biotechnol 2011, 5:1-11.
129. Lin C.Y., Lin K.-J., Kao C.-Y., et al. Adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus augment the healing of massive bone defects. Spine 2011, 22:1-13.
130. Liu X., Li K., Song J., et al. Efficient and stable gene expression in rabbit intervertebral disc cells transduced with a recombinant baculovirus vector. Spine 2006, 31:732-735.
131. Liu C.Y.-Y., Wang C.-H., Wang J.-C., et al. Stimulation of baculovirus transcriptome expression in mammalian cells by baculoviral transcriptional activators. J Gen Virol 2007, 88:2176-2184.
132. Liu C.Y.-Y., Wang C.-H., Hsiao W.-K., et al. RING and Coiled-Coil domains of baculovirus IE2 are critical in strong activation of the cytomegalovirus major immediate-early promoter in mammalian cells. J Virol 2009, 83:3604-3616.
133. Liu Z.-S., Xu Y.-F., Feng S.-W., et al. Baculovirus-transduced mouse amniotic fluid-derived stem cells maintain differentiation potential. Ann Hematol 2009, 88:565-572.
134. Liu C.Y.-Y., Chen H.-Z., Chao Y.-C. Maximizing baculovirus-mediated foreign proteins expression in mammalian cells. Curr Gene Ther 2010, 10:232-241.
135. Lo H.-R., Chao Y.-C. Rapid titer determination of baculovirus by quantitative real-time polymerase chain reaction. Biotechnol Prog 2004, 20:354-360.
136. Lo W.-H., Hwang S.-M., Chuang C.-K., et al. Development of a hybrid baculoviral vector for sustained transgene expression. Mol Ther 2009, 17:658-666.
137. Lo W.-H., Chen C.-Y., Yeh C.-N., et al. Rapid baculovirus titration based on regulatable green fluorescent protein expression in mammalian cells. Enzyme Microb Technol 2011, 48:13-18.
138. Long G., Pan X., Kormelink R., et al. Functional entry of baculovirus into insect and mammalian cells is dependent on clathrin-mediated endocytosis. J Virol 2006, 80:8830-8833.
139. Lu L.-Q., Ho Y.-F., Kwang J. Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem Biophys Res Commun 2006, 340:1178-1183.
140. Lu L., Yu L., Kwang J. Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun 2007, 358:404-409.
141. Lucifora J., Durantel D., Belloni L., et al. Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector. J Gen Virol 2008, 89:1819-1828.
142. Madhan S., Prabakaran M., Kwang J. Baculovirus as vaccine vectors. Curr Gene Ther 2010, 10:201-213.
143. Mahonen A.J., Airenne K.J., Purola S., et al. Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells. J Biotechnol 2007, 131:1-8.
144. Mahonen A.J., Makkonen K.E., Laakkonen J.P., et al. Culture medium induced vimentin reorganization associates with enhanced baculovirus-mediated gene delivery. J Biotechnol 2010, 145:111-119.
145. Makela A.R., Oker-Blom C. Baculovirus display: A multifunctional technology for gene delivery and eukaryotic library development. Adv Virus Res 2006, 68:91-112.
146. Makela A.R., Matilainen H., White D.J., et al. Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides. J Virol 2006, 80:6603-6611.
147. Makela A.R., Enback J., Laakkonen J.P., et al. Tumor targeting of baculovirus displaying a lymphatic homing peptide. J Gene Med 2008, 10:1019-1031.
148. Martyn J.C., Cardin A.J., Wines B.D., et al. Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors. Arch Virol 2009, 154:1129-1138.
149. Matilainen H., Rinne J., Gilbert L., et al. Baculovirus entry into human hepatoma cells. J Virol 2005, 79:15452-15459.
150. Matsuo E., Tani H., Lim C.k., et al. Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem Biophys Res Commun 2006, 340:200-208.
151. McCormick C.J., Rowlands D.J., Harris M. Efficient delivery and regulable expression of hepatitis C virus full-length and minigenome constructs in hepatocyte-derived cell lines using baculovirus vectors. J Gen Virol 2002, 83:383-394.
152. Merrihew R.V., Clay W.C., Condreay J.P., et al. Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells. J Virol 2001, 75:903-909.
153. Mlambo G., Kumar N., Yoshida S. Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen. Vaccine 2010, 28:7025-7029.
154. Molinari P., García-Nuñez S., Gravisaco M.J., et al. Baculovirus treatment fully protects mice against a lethal challenge of FMDV. Antiviral Res 2010, 87:276-279.
155. (™) 293 cells for the generation of influenza B/Lee/40. Mol Biotechnol 2006, 34:157-164.
156. Nicholson L.J., Philippe M., Paine A.J., et al. RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol Ther 2005, 11:638-644.
157. Niu M.S., Han Y., Li W.L. Baculovirus up-regulates antiviral systems and induces protection against infectious bronchitis virus challenge in neonatal chicken. Int Immunopharmacol 2008, 8:1609-1615.
158. Nizamani Z.A., Keil G.M., Albina E., et al. Potential of adenovirus and baculovirus vectors for the delivery of shRNA against morbilliviruses. Antiviral Res 2011, 90(1):98-101.
159. Ong S.-T., Li F., Du J., et al. Hybrid cytomegalovirus enhancer-H1 promoter-based plasmid and baculovirus vectors mediate effective RNA interference. Hum Gene Ther 2005, 16:1404-1412.
160. Pan Y., Zhao Q., Fang L., et al. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon. J Gene Med 2009, 11:1030-1038.
161. Pan Y., Fang L., Fan H., et al. Antitumor effects of a recombinant pseudotype baculovirus expressing Apoptin in vitro and in vivo. Int J Cancer 2010, 126:2741-2751.
162. Paul A., Prakash S. Baculovirus reveals a new pH-dependent direct cell-fusion pathway for cell entry and transgene delivery. Future Virol 2010, 5:533-537.
163. Peralta A., Molinari P., Conte-Grand D., et al. A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties. Appl Microbiol Biotechnol 2007, 75:407-414.
164. Ping W.-X., Ge J.-P., Li S.-X., et al. Baculovirus-mediated gene expression in chicken primary cells. Avian Dis 2006, 50:59-63.
165. Prabakaran M., Velumani S., He F., et al. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology 2008, 380:412-420.
166. Prabakaran M., He F., Meng T., et al. Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages. J Virol 2010, 84:11822-11830.
167. Prabakaran M., Madhan S., Prabhu N., et al. Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice. Antiviral Res 2010, 86:180-187.
168. Prabakaran M., Madhan S., Prabhu N., et al. Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection. J Virol 2010, 84:3201-3209.
169. Raty J.K., Airenne K.J., Marttila A.T., et al. Enhanced gene delivery by avidin-displaying baculovirus. Mol Ther 2004, 9:282-291.
170. Raty J.K., Liimatainen T., Wirth T., Airenne K.J., Ihalainen T.O., Huhtala T., et al. Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther. 2006, 13:1440-1446.
171. Raty J.K., Liimatainen T., Huhtala T., Kaikkonen M.U., Airenne K.J., Hakumaki J.M., et al. SPECT/CT imaging of baculovirus biodistribution in rat. Gene Ther. 2007, 14:930-938.
172. Roldao A., Oliveira R., Carrondo M.J.T., et al. Error assessment in recombinant baculovirus titration: evaluation of different methods. J Virol Methods 2009, 159:69-80.
173. Salminen M., Airenne K.J., Rinnankoski R., Reimari J., Valilehto O., Rinne J., et al. Improvement in nuclear entry and transgene expression of baculoviruses by disintegration of microtubules in human hepatocytes. J Virol. 2005, 79:2720-2728.
174. Shan L., Wang L.Y., Yin J., Zhong P., Zhong J. An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression. J Gene Med 2006, 8:1400-1406.
175. Schutz A., Scheller N., Breinig T., et al. The Autographa californica nuclear polyhedrosis virus AcNPV induces functional maturation of human monocyte-derived dendritic cells. Vaccine 2006, 24:7190-7196.
176. Shen H.-C., Lee H.-P., Lo W.-H., et al. Baculovirus-mediated gene transfer is attenuated by sodium bicarbonate. J Gene Med 2007, 9:470-478.
177. Shen H.-C., Yeh C.-N., Chen G.-Y., et al. Sustained baculovirus-mediated expression in myogenic cells. J Gene Med 2008, 10:1190-1197.
178. Sollerbrant K., Elmen J., Wahlestedt C., Acker J., Leblois-Prehaud H., Latta-Mahieu M., et al. A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors. J Gen Virol. 2001, 82:2051-2060.
179. Song S.-U., Shin S.-H., Kim S.-K., et al. Effective transduction of osteogenic sarcoma cells by a baculovirus vector. J Gen Virol 2003, 84:697-703.
180. Song J.-H., Liang C.-Y., Chen X.-W. Transduction of avian cells with recombinant baculovirus. J Virol Methods 2006, 135:157-162.
181. Song L., Liu Y.-Y., Chen J.-C. Baculoviral capsid display of His-tagged ZnO inorganic binding peptide. Cytotechnology 2010, 62:133-141.
182. Starkey J.L., Chiari E.F., Isom H.C. Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro. J Gen Virol 2009, 90:115-126.
183. Strauss R., Huser A., Ni S., et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 2007, 15:193-202.
184. Sung L.-Y., Lo W.-H., Chiu H.-Y., et al. Modulation of chondrocyte phenotype via baculovirus-mediated growth factor expression. Biomaterials 2007, 28:3437-3447.
185. Sung L.-Y., Chiu H.-Y., Chen H.-C., et al. Baculovirus-mediated growth factor expression in dedifferentiated chondrocytes accelerates redifferentiation: Effects of combinational transduction. Tissue Eng Part A 2009, 15:1353-1362.
186. Suzuki H., Matsumoto N., Suzuki T., et al. Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy. Virol J 2009, 6:156-163.
187. Suzuki H., Saitoh H., Suzuki T., et al. Baculovirus-mediated bispecific short-hairpin small-interfering RNAs have remarkable ability to cope with both influenza viruses A and B. Oligonucleotides 2009, 19:307-316.
188. Suzuki H., Tamai N., Habu Y., et al. Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression. FEBS Lett 2009, 582:3085-3089.
189. Suzuki T., Chang M.O., Kitajima M., et al. Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses. Cell Immunol 2010, 262:35-43.
190. Suzuki T., Oo Chang M., Kitajima M., et al. Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells. Cell Mol Immunol 2010, 7:440-446.
191. Syed Musthaq S., Madhan S., Hameed A.S.S., et al. Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon. Virology 2009, 391:315-324.
192. Tami C., Peralta A., Barbieri R., et al. Immunological properties of FMDV-gp64 fusion proteins expressed on SF9 cell and baculovirus surfaces. Vaccine 2004, 23:840-845.
193. Tang X.C., Lu H.R., Ross T.M. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Vaccine 2010, 28:6821-6831.
194. Tani H., Nishijima M., Ushijima H., et al. Characterization of cell-surface determinants important for baculovirus infection. Virology 2001, 279:343-353.
195. Tani H., Limn C.-K., Yap C.-C., et al. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 2003, 77:9799-9808.
196. Tani H., Abe T., Matsunaga T.M., et al. Baculovirus vector for gene delivery and vaccine development. Future Virol 2008, 3:35-43.
197. Transfiguracion J., Jorio H., Meghrous J., et al. High yield purification of functional baculovirus vectors by size exclusion chromatography. J Virol Methods 2007, 142:21-28.
198. Tsai C.-T., Chan Z.-R., Lu J.-T., et al. Factors influencing the production and storage of baculovirus for gene delivery: an alternative perspective from the transducing titer assay. Enzyme Microb Technol 2007, 40:1345-1351.
199. van Loo N.D., Fortunati E., Ehlert E., et al. Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J Virol 2001, 75:961-970.
200. Vicente T., Peixoto C., Carrondo M.J.T., et al. Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther 2009, 16:766-775.
201. Vicente T., Mota J.P.B., Peixoto C., et al. Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance. J Biotechnol 2010, 148:171-181.
202. Vicente T., Peixoto C., Alves P.M., et al. Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development. J Chromatogr A 2010, 1217:3754-3764.
203. Wagle M., Jesuthasan S. Baculovirus-mediated gene expression in zebrafish. Mar Biotechnol 2003, 5:58-63.
204. Wang S., Balasundaram G. Potential cancer gene therapy by baculoviral transduction. Curr Gene Ther 2010, 10:214-225.
205. Wang K.-C., Wu J.-C., Chung Y.-C., et al. Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells. Biotechnol Bioeng 2005, 89:464-473.
206. Wang C.-Y., Li F., Yang Y., et al. Recombinant baculovirus containing the Diphtheria toxin A gene for malignant glioma therapy. Cancer Res 2006, 66:5798-5806.
207. Wang S.-P., Fang L.-R., Fan H.-Y., et al. Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 2007, 25:8220-8227.
208. Wang L.Y., Shan L., Lo K.W., Yin J., Zhang Y.Y., Sun R., et al. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP. J Gene Med 2008, 10:1124-1133.
209. Wang X., Yin J., Huang X.-X., et al. DNA methyltransferase inhibitors increase baculovirus-mediated gene expression in mammalian cells when applied before infection. Anal Biochem 2010, 396:322-324.
210. Wilson S., Baird M., Ward V.K. Delivery of vaccine peptides by rapid conjugation to baculovirus particles. Vaccine 2008, 26:2451-2456.
211. Wu C., Soh K.Y., Wang S. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum Gene Ther 2007, 18:665-672.
212. Wu C., Lin J., Hong M., et al. Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. Mol Ther 2009, 17:2058-2066.
213. Wu Q.-F., Fang L.-R., Wu X.-B., et al. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens. Mol Immunol 2009, 46:2210-2217.
214. Xu X.-G., Liu H.-J. Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model. Vaccine 2008, 26:5455-5460.
215. rns envelope glycoprotein of classical swine fever virus. J Virol Methods 2008, 153:149-155.
216. Xu X.-G., Tong D.-W., Chiou M.-T., et al. Baculovirus surface display of NS3 nonstructural protein of classical swine fever virus. J Virol Methods 2009, 159:259-264.
217. Xu X.-G., Wang Z.-S., Zhang Q., et al. Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models. Vaccine 2011, 29:636-643.
218. Yan Y., Du J., Chen T.-S., et al. Establishment of medakafish as a model for stem cell-based gene therapy: efficient gene delivery and potential chromosomal integration by baculoviral vectors. Exp Cell Res 2009, 315:2322-2331.
219. Yang D.-G., Chung Y.-C., Lai Y.-K., et al. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther 2007, 15:989-996.
220. Yang Y., Lo S.-L., Yang J.-Y., et al. Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials 2009, 30:5767-5774.
221. Yin H.-Y., Zhou X.-A., Wu H.-F., et al. Baculovirus vector-mediated transfer of NIS gene into colon tumor cells for radionuclide therapy. World J Gastroenterol 2010, 16:5367-5374.
222. Yoshida S., Kondoh D., Arai E., et al. Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology 2003, 316:161-170.
223. Yoshida S., Kawasaki M., Hariguchi N., et al. A baculovirus dual expression system-based malaria vaccine induces strong protection against Plasmodium berghei sporozoite challenge in mice. Infect Immun 2009, 77:1782-1789.
224. Yoshida S., Araki H., Yokomine T. Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice. Infect Immun 2010, 78:595-602.
225. Yu I.L., Lin Y.C., Robinson J.H., Lung O. Transduction of vertebrate cells with Spodoptera exigua multiple nucleopolyhedrovirus F protein-pseudotyped gp64-null Autographa californica multiple nucleopolyhedrovirus. J Gen Virol. 2009, 90:2282-2287.
226. Zeng J.-M., Du J., Lin J.-K., et al. High-efficiency transient transduction of human embryonic stem cell-derived neurons with baculoviral vectors. Mol Ther 2009, 17:1585-1593.
227. Zhang Y., Lv Z., Chen J., et al. A novel method for isolation of membrane proteins: a baculovirus surface display system. Proteomics 2008, 8:4178-4185.
228. Zheng H., Liu C., Zhuang J., et al. Baculovirus expression of cloned porcine arterivirus generates infectious particles in both insect and mammalian cells. J Biotechnol 2010, 150:251-258.
229. Zhou J., Blissard G.W. Display of Heterologous proteins on gp64null baculovirus birions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct. J Virol 2008, 82:1368-1377.
230. Zhou X., Li B., Wang J., et al. The feasibility of using a baculovirus vector to deliver the sodium-iodide symporter gene as a reporter. Nucl Med Biol 2010, 37:299-308.